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Rat cytomegalovirus (RCMV) is a-herpesvirus with a 230-kbp genome containing over 167 open reading frames
(ORFs). RCMV gene expression is tightly regulated in cultured cells, occurring in three distinct kinetic classes
(immediate early, early, and late). However, the extent of viral-gene expression in vivo and its relationship to the in
vitro expression are unknown. In this study, we used RCMV-specific DNA microarrays to investigate the viral
transcriptional profiles in cultured, RCMV-infected endothelial cells, fibroblasts, and aortic smooth muscle cells
and to compare these profiles to those found in tissues from RCMV-infected rat heart transplant recipients. In
cultured cells, RCMV expresses approximately 95% of the known viral ORFs with few differences between cell types.
By contrast, in vivo viral-gene expression in tissues from rat heart allograft recipients is highly restricted. In the
tissues studied, a total of 80 viral genes expressing levels twice above background (5,000 to 10,000 copies perg total
RNA) were detected. In each tissue type, there were a number of genes expressed exclusively in that tissue. Although
viral mRNA and genomic DNA levels were lower in the spleen than in submandibular glands, the number of
individual viral genes expressed was higher in the spleen (60 versus 41). This finding suggests that the number of
viral genes expressed is specific to a given tissue and is not dependent upon the viral load or viral mRNA levels. Our
results demonstrate that the profiles, as well as the amplitude, of viral-gene expression are tissue specific and are
dramatically different from those in infected cultured cells, indicating that RCMV gene expression in vitro does not
reflect viral-gene expression in vivo.
Cytomegaloviruses (CMV) are ubiquitous -herpesviruses
that establish lifelong latent infections following primary infec-
tion. Although antiviral therapy has significantly reduced dis-
ease in transplant and AIDS patients, human CMV (HCMV)
still is a significant problem in congenital disease and bone
marrow transplant patients (23). In these infected individuals,
HCMV can manifest itself in a number of CMV-related acute
diseases, including retinitis, encephalitis, gastritis, and mono-
nucleosis. In addition, HCMV has also been associated with
long-term diseases, such as atherosclerosis, chronic rejection
following solid-organ transplantation, and, more recently, ma-
lignancies (9). CMV is one of the largest human viruses known,
with over 200 open reading frames (ORFs), and a number of
viral genes have been implicated in the development of CMV-
related diseases. However, the in vivo expression profiles of
these and other viral genes are unknown. Therefore, a com-
prehensive profiling of CMV gene expression during infection
in the host is warranted. In addition, it is important to deter-
mine whether one can use the viral-gene expression patterns
seen in in vitro models of virus-infected cells to predict those
patterns seen in vivo.
In cultured cells, CMV gene expression occurs in three ki-
netic phases designated immediate early (IE), early (E), and
late (L) (21). These phases were defined through the use of
drugs that target either cellular translation or the viral DNA
polymerase. Transcription of IE genes begins shortly following
virus penetration and uncoating and does not require de novo
protein synthesis. The IE proteins enhance transcription from
both host and viral promoters, leading to the expression of the
E genes, which include genes involved in viral DNA replica-
tion, such as the viral DNA polymerase gene (UL54). L viral
genes are expressed following viral DNA synthesis, thus mak-
ing expression of this class of genes sensitive to inhibitors of
the viral DNA polymerase. The L viral-gene kinetic class is
generally involved in viral DNA packaging, assembly, and
egress. Recently, virus-specific DNA microarray analysis has
been utilized to classify global viral gene transcription of her-
pes simplex virus type 1 and HCMV (8, 11, 12, 25). Goodrum
et al. used HCMV-specific microarrays to examine HCMV
gene expression in latently infected CD34 hematopoietic pro-
genitors (11, 12). A subset of HCMV genes representing IE, E,
and L stages of infection were detected in these latently in-
fected cell cultures at 1, 5, and 8 days postinfection. However,
in these experiments, the investigators did not identify an ob-
vious pattern of viral-gene expression that represented a po-
tential kinetic class of latency genes. The HCMV genes ex-
pressed during the establishment of latency in this system may
represent an initial burst of expression followed by viral qui-
escence in the cell. Interestingly, the extent of viral-gene ex-
pression was dependent upon the status of cellular differenti-
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ation. An important question related to these studies concerns
the relevance of HCMV gene expression prior to the develop-
ment of latency and how this relates to viral-gene expression
during viral persistence in vivo.
The RCMV-rat model has proven to be an important tool
for studying mechanisms involved in CMV-related diseases,
including the effect of the virus on accelerated solid-organ
transplant rejection. Infection of immunocompetent rats leads
to a limited subclinical infection that typically persists in the
columnar epithelial cells of the submandibular glands (SMG)
for up to 180 days postinfection (p.i.) (2, 3). RCMV infection
of immunocompromised rats causes a widespread infection of
most tissues, infecting a number of different cell types, includ-
ing endothelial cells (EC), epithelial cells, macrophages, poly-
morphonuclear cells, and fibroblasts. In this report, we profiled
viral-gene expression utilizing microarrays containing DNA
oligonucleotides specific for the 167 known RCMV ORFs (19).
We compared viral-gene expression in cultured rat fibroblasts,
vascular smooth muscle cells (SMC), and aortic EC to the
expression profiles observed in the tissues from RCMV-in-
fected allograft recipients, including SMG (the site of virus
persistence), allograft heart, lung, liver, kidney, and spleen. We
observed that the pattern of RCMV gene expression in vivo
differs dramatically from that in RCMV-infected cultured cells.
Our data suggest that RCMV gene expression is highly tissue
specific. Importantly, the majority of the RCMV genes ex-
pressed at high levels in tissues are not known to be involved in
virus replication but may represent the profile of immune mod-
ulator genes required for CMV persistence.
MATERIALS AND METHODS
RCMV. SMG-derived stocks of the Maastricht strain of RCMV were titered
using rat embryo fibroblasts (REFs) (3, 7). Plaque assays were performed in
confluent 24-well plates by infection with an appropriate serial virus dilution in
0.2 ml of medium and then incubated at 37°C for 90 min. Following incubation,
the infected cells were rinsed with phosphate-buffered saline (PBS) and overlaid
with 1 ml Eagle minimal essestial medium supplemented with 10% fetal calf
serum, nonessential amino acids, penicillin-streptomycin, and 20 mM L-glu-
tamine with a final concentration of 0.6% agarose (Sigma, St. Louis, MO). After
7 days, the cells were fixed in 10% formalin in PBS and stained with 0.05%
aqueous methylene blue (Sigma). The plaques were counted by light microscopy.
RCMV infection of tissue culture cells. Primary aortic SMC, aortic EC, and
REFs were isolated from F344 rats and maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal calf serum and penicillin-strepto-
mycin-glutamine (20, 26). The EC phenotype was confirmed by staining these
cells with antibodies directed against von Willebrand factor. These cells exhibited
characteristics and morphology typical of their origin when maintained in culture
beyond passage 15 (data not shown). REFs, SMC, and EC were plated on 60-mm
dishes (Costar) and infected with RCMV upon confluence at a multiplicity of
infection equal to 0.1. After 2 hours, the cells were washed three times with PBS.
The infected cells were harvested at 4, 8, 16, 24, 36, and 48 h p.i. by first washing
them once with PBS and then adding 1 ml of Trizol reagent. The reagent was
allowed to lyse the cells for 5 min. Subsequently, the samples were stored frozen
at 80°C.
Preparation of rat tissues. In order to determine viral-gene expression in vivo,
we isolated RNA from the SMG, lungs, liver, kidney, spleen, and graft hearts
from allograft recipients (26). For these studies, adult male F344 rats (Harlan
Sprague-Dawley, Indianapolis, IN) served as allogeneic heart donors, while
Lewis rats (Harlan Sprague-Dawley) served as solid-organ transplant recipients
(26). To prevent acute rejection, Lewis recipients were treated with low-dose
cyclosporine for 10 days (5 mg/kg of body weight/day; Sandoz Inc., East Hanover,
NJ). In all animals, the native heart remained intact. Acute RCMV infection was
accomplished by injecting 1  105 PFU of RCMV intraperitoneally on day 1
following the heart transplant operation. The tissues were harvested from allo-
graft recipients at 7, 14, 21, and 28 days posttransplantation. Total RNA was
prepared from 0.25 g of rat tissues using the Trizol method. All animals were
housed in the Portland VA Medical Center animal facilities in a specific-patho-
gen-free room. This facility is AAALAC accredited and complies with the re-
quirements for animal care as stipulated by the U.S. Department of Agriculture
and HHS.
RCMV microarray techniques. The Spotted Microarray Core at the Vaccine
and Gene Therapy Institute, Oregon Health and Science University (http://www
.ohsu.edu/gmsr/smc/), printed the RCMV microarray used for this study. Each
slide contained two unique 70-mer antisense oligonucleotides for each of the 167
predicted viral ORFs (29) and an additional 2,925 rat cellular genes. The RCMV
gene slides were printed on aminosilane-coated glass slides using the Cartesian
PixSys 5500 XL microarray printer (Genomic Solutions; located at the Spotted
Microarray Core), and each cDNA was spotted twice to account for intrachip
variation. The oligonucleotides were chosen with a 3 bias and compared against
the NCBI database for alignment to the genome sequence of the RCMV Maas-
tricht strain and for possible cross-hybridization to cellular sequences.
First-strand cDNA was synthesized from 2 g of total RNA using 1.0 M
oligo(dT)-T7 primer [GGCCAGTGAATTGTAATACGACTCACTATAGGG
(A)24] and 200 U Superscript III reverse transcriptase (Invitrogen). Doubled-
stranded cDNA was generated by the addition of second-strand buffer (Invitro-
gen) according to the manufacturer’s protocol and purified by phenol-chloro-
form–isoamyl alcohol extraction. The cDNA was amplified for one round using
the T7 Megascript Kit (Ambion) to produce amplified RNA (aRNA), which was
purified using the RNeasy Mini kit (QIAGEN). Five micrograms of aRNA was
reverse transcribed with 300 U Superscript III reverse transcriptase in the pres-
ence of 9 g of random hexamers; 0.5 mM (each) dATP, dGTP, and dCTP; 0.35
mM dTTP; and 0.15 mM aminoallyl dUTP. aRNA was hydrolyzed with 0.3 N
NaOH (70°C for 10 min) and then neutralized with 0.625 M HEPES (pH 7.5).
Aminoallyl-labeled cDNA was purified using the Cyscribe GFX Purification Kit
(Amersham) and coupled to Cy3 or Cy5 fluorescent dye (Amersham) through
the incorporated aminoallyl UTP. The labeled cDNA was purified using the
Cyscribe GFX Purification Kit (Amersham) and then hybridized to microarray
slides in the presence of Slide Hybe no. 2 (Ambion) at 65°C for 18 h. The slides
were washed consecutively with 0.5 SSC (1 SSC is 0.15 M NaCl plus 0.015 M
sodium citrate)-0.1% sodium dodecyl sulfate, 0.06 SSC-0.1% sodium dodecyl
sulfate, and 0.06 SSC for 5 min at room temperature. All slides were scanned
using a Bioscience GeneScan Lite laser scanner and analyzed using Imagene
digital processing software and Genesight data analysis software (Biodiscovery).
Local background values were subtracted using Imagene 3.5.1 software, and
genes determined to be “on” had values twice that of the background.
Quantitative RT-PCR detection of RCMV gene expression. Real-time reverse
transcriptase (RT) PCR was used to confirm and quantify the RCMV gene
expression results obtained using microarray analysis. cDNA was generated as
described above using Superscript III RT (Invitrogen) and analyzed by real-time
PCR techniques using primer sets recognizing RCMV gene sequences (Table 1).
The primer sets were identified using Primer Express software (Applied Biosys-
tems). RT-PCRs were performed using the SYBR Green PCR Master Mix
(Applied Biosystems), except for PCRs for R78, r119.1, r119.2, r151, and r152.4,
which were performed using specific TaqMan probes and Master Mix. Following
thermal activation of AmpliTaq Gold (10 min at 95°C), a total of 40 cycles were
performed (15 s at 95°C and 1 min at 58°C) using the ABI Prism 7700 Sequence
Detection System (Applied Biosystems). Plasmid clones containing each gene
fragment were used as positive controls and quantification standards. PCR
results were analyzed using ABI Prism 7700 Sequence Detection Software. The
sensitivity of detection of this assay was 100 plasmid copies for all of the tested
RCMV genes.
Statistical analysis. Quantitative PCR data were analyzed by analysis of vari-
ance and Student’s t test. P values of 0.05 were considered significant.
RESULTS
Profiling RCMV gene expression in vitro. RCMV infects a
number of different cell types both in vivo and in vitro, includ-
ing EC, SMC, epithelial cells, fibroblasts, and macrophages
(17, 28). Similar to HCMV, the RCMV genome is about 230
kbp and includes 167 predicted ORFs (29). Whether CMV
gene expression differs in various cell types or how in vivo
viral-gene expression compares to that observed in cultured
cells has not been reported. In order to answer these important
questions, we generated RCMV microarrays to profile viral-
gene expression both in vivo and in vitro. The RCMV microar-
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ray slides contained two unique, nonoverlapping 70-mer anti-
sense oligonucleotides for each of the 167 predicted viral
ORFs (29) and an additional 2,925 rat cellular genes used to
normalize the data. The oligonucleotides were chosen with a 3
bias and compared against the NCBI database for alignment to
the RCMV Maastricht strain and for possible cross-hybridiza-
tion to cellular sequences. The specificity of the RMCV mi-
croarray was confirmed by hybridization of labeled RCMV
genomic DNA, which bound each of the viral oligonucleotides
on the chip but did not display binding activity toward the
cellular control oligonucleotides (data not shown).
In order to determine whether RCMV gene expression is
cell type specific, rat fibroblasts, aortic SMC, and aortic EC
were infected with RCMV and harvested at 4, 8, 16, 24, 36, and
48 h p.i. Then, RNA was purified from the cells and reverse
transcribed into doubled-stranded cDNA. The cDNA was la-
beled and hybridized to RCMV microarray slides for 18 h. The
slides were washed, scanned, and analyzed. A typical microar-
ray analysis of RCMV gene expression in infected REFs is
shown in Fig. 1. RCMV gene expression profiles for infected
REFs, SMCs, and ECs at 4, 16, and 48 h p.i. are depicted in
Fig. 2 as the average intensity above background. At 4 h p.i.,
only two genes, r123Exon4 (IE1) and r128, were highly ex-
pressed in all cell types. However, by 16 h p.i., nearly 80% of
RCMV genes were expressed at detectable levels. Ninety-six
viral genes (60% of the predicted viral ORFs) were expressed
with early kinetics in RCMV-infected REFs treated with phos-
phonoacetic acid and harvested at 48 h p.i. (Table 2). Maximal
RCMV gene expression occurs at 36 and 48 h p.i., when over
87% of the viral genes are expressed (Fig. 2 and Table 2). Since
labeled RCMV DNA bound to all of the viral oligonucleotides
on the chip (data not shown), it is likely that the 10 to 13% of
RCMV genes that failed to be detected represent either genes
with unknown splicing properties or genes that are expressed
at very low levels. These genes were also not detected in RNA
samples isolated from in vivo-infected tissues, as described
below. A positive signal on our RCMV DNA microarray re-
quired that any given gene express 5,000 to 10,000 copies of
mRNA in 2 g of starting total RNA (data not shown). This
was determined by comparing quantitative real-time RT-PCR
(QRT-PCR) evaluation of the expression of at least 15 RCMV
genes to the microarray results from 10 different samples in
which gene expression varied for the particular gene of interest
from negative to positive. Interestingly, according to our mi-
croarray results, there are at least seven genes expressed ex-
clusively in ECs, one in SMCs, and three in REFs. Our findings
suggest that, other than a small subset of genes, RCMV gene
expression is not cell type specific in vitro.
Profiling RCMV gene expression in vivo. In order to explore
viral-gene expression in vivo, RCMV microarray slides were
utilized to initially analyze RNA isolated from SMG from
RCMV-infected heterotopic heart allograft recipients. For
these studies, adult F344 rats served as allogeneic heart do-
nors, while Lewis rats served as transplant recipients (22, 26).
RNA was isolated from heart allograft recipient tissues har-
vested at 7, 14, 21, and 28 days posttransplantation. The RNA
was converted to cDNA, labeled, and hybridized to the RCMV
microarray chips as described above. Interestingly, on day 7, in
RNA samples from each of the four rats tested, only two
RCMV genes (R116 and r152.4) were expressed to at least
twice the background level. These genes constitute approxi-
mately 1% of the known RCMV genes (Fig. 3). This finding is
not surprising, since previous studies had demonstrated that
RCMV takes approximately 14 days to establish infection in
SMG (5, 6, 17, 26). Approximately 11% of the RCMV genes
are expressed at 14 days p.i., and this number increases to
nearly 25% by day 21, which includes genes expressed with IE,
FIG. 1. Microarray analysis of RCMV gene expression. Each chip
contained two unique oligonucleotides for each viral gene, and these
oligonucleotides were spotted in duplicate. The RCMV oligonucleo-
tides were distributed over four positions on each chip depicted in
grids A to D. The yellow lines outline the positions of the RCMV-
specific oligonucleotides. The data shown represent microarray anal-
ysis of RNA extracted from RCMV-infected REFs at 4, 8, 16, 24, 36,
and 48 h p.i.
TABLE 1. Quantitative PCR primer sequences
RCMV ORF Primer sequence
R32 Forward......................5-ATC CGG TCC ATG AGG TCG A
R32 Reverse.......................5-GTG ATC AAT GAA TGT CGC GG
R33 Forward......................5-ACC CTG ACG TTC GTG ACG AC
R33 Reverse.......................5-TGA TCG GCC AGT TCA GCA C
R35 Forward......................5-CCC TGA CCG TGT TCA AGA GG
R35 Reverse.......................5-GAC TTT CGC ATG GCG ATC A
R49 Forward......................5-CGC GGT ATC GTT ATG GGT G
R49 Reverse.......................5-ATG GGC AAG GAC AAA CTC GA
R75 Forward......................5-CTT CCG CAG AAC TCG CAG TG
R75 Reverse.......................5-CCT GCG TCT ACA GCA CCT CCT A
R78 Forward......................5-CTT CTA CGC CCT GCA CTT CG
R78 Reverse.......................5-GCC AGC TCG TAG TAC CCG AC
R114 Forward....................5-ACC TTT ACG GAA CCG GAG TTG
R114 Reverse.....................5-ACG GAC AAG GTC GAT AGG GA
R116 Forward....................5-TCC GGC TGA ATA AGA CCT CG
R116 Reverse.....................5-CCC ATC CTC AAC AGC ACA CA
r119.1 Forward ..................5-TTC GGA ATC GAT GGT GAC AAG
r119.1 Reverse ...................5-CAC TCA TCG CCG TCA ACA GA
r119.2 Forward ..................5-GTT CCA TCG GCA TCA TGT AAG A
r119.2 Reverse ...................5-ACG ACG CTA ATG AAA CTG GCA
r119.4 Forward ..................5-GTT CCA CTG AGA CTG CTT GCG
r119.4 Reverse ...................5-CAG GAT TAT TTG GCG GCA AC
r123 Forward .....................5-CCA CTA TCT TGG GCA CGG A
r123 Reverse ......................5-ACC GAA ACC TTC AGA CAA CCA
r148 Forward .....................5-TAC GAC CCA CGT CAA AAG TTG A
r148 Reverse ......................5-ATC TCT ATG TCG TTT ACT GCG A
r149 Forward .....................5-GAA CCG CGG ATT CGT AGT CTC
r149 Reverse ......................5-ATT CCA GTG ACA CCG AGG GA
r151 Forward .....................5-AAT CCA TTT TGT GGT CCA AGG A
r151 Reverse ......................5-TCG ATG ACC GTT GGA GGA AC
r152.4 Forward ..................5-ACC TTC GAG CCA ATG TGA ATG
r152.4 Reverse ...................5-CAA CGT CTC AGA TGC GGA GA
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E, and L kinetics. The number of RCMV genes expressed
decreased to 15% on day 28 (Fig. 3). Compared to the 87%
transcriptionally active genes observed in the RCMV-infected
tissue culture cells, the number of transcripts detected in vivo
was quite low. This difference was not due to lower signal
intensity. Rather, there was a clear bias in gene expression. For
instance, even at day 21, when the greatest numbers of RCMV
genes are expressed, only a few of these genes are known to be
involved in virus replication. In fact, most of these highly ex-
pressed genes are in clusters on the right half of the RCMV
genome, which is the region that contains genes thought to be
involved in host cell manipulation and/or immune evasion (19).
For example, r151 was highly expressed in the SMG of infected
rats. The r151 gene is a homolog of the murine CMV m152
gene, which blocks cell surface expression of major histocom-
patibility complex class I in infected cells through retention of
the protein in the cis-Golgi compartment (10, 16, 18).
To rule out the possibility that technical reasons were the
cause of differences in expression patterns observed in vitro
versus in vivo, we used QRT-PCR to quantify the RCMV
transcript levels. Shown in Fig. 4A are the normalized average
copy numbers of R33 (vGPCR), R75 (gH), R114, R116,
r119.1, r119.2, r119.4, r123 (IE1), and r151 as detected by
QRT-PCR in SMG tissue from four RCMV-infected rats. The
levels of IE1 (r123) and other essential genes, such as gH
(R75), were more than 100-fold lower than the expression
levels of r119.1, r119.2, and r151. By contrast, in cultured
RCMV-infected fibroblasts, the expression levels of IE1 were
much higher than those of r119.1 at early time points (4 and 8 h
p.i.), whereas at later time points, the expression levels of these
genes were similar (Fig. 4B). Additionally, by 16 h p.i. the
expression levels of gH in the RCMV-infected cultured cells
were 10- to-100-fold higher than those of r119.1. These find-
ings confirm the trend observed by microarray analysis and
indicate that in vitro, RMCV gene expression profiles do not
accurately predict the levels of gene expression found in vivo.
RCMV gene expression is tissue specific. To determine
whether the RCMV gene expression pattern of SMG is also
observed in other tissues, we profiled viral transcription in
lungs, liver, kidney, spleen, and native and allograft hearts
harvested from the transplant recipients (n  4). The tissues
harvested at days 7, 14, 21, and 28 were prescreened for viral
DNA and mRNA by quantitative PCR in order to identify
tissues containing appropriate levels of viral message to be
detected by microarray analysis. Previous studies have indi-
cated that wild-type RCMV DNA levels directly reflect the
viral load in rat tissues (14, 15). At 7 days p.i., viral-DNA levels
in the allograft heart, spleen, lung, liver, SMG, and kidney
ranged from 5  104 to 2  105 RCMV genomic equivalents
per g of input DNA (Table 3). The level of viral DNA in the
FIG. 2. RCMV in vitro gene expression. Fluorescence intensities from microarray analysis of RCMV RNAs isolated from infected REFs (A),
SMC (B), and EC (C) harvested at 4, 16, and 48 h p.i. The RNA was amplified, and cDNA samples were labeled and hybridized to the RCMV
microarray chips containing oligonucleotides specific for all of the known viral genes.
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SMG at 14 days p.i. was approximately 1  107 genomic equiv-
alents per g of input DNA, which increased at 21 and 28 days
p.i. to approximately 1  108 to 3  108. All of the tissues,
except the native heart, tested positive for viral mRNAs
(r119.2 and r151) at 7 days p.i. (data not shown), which was
consistent with the detection of viral DNA (Table 3). As ex-
pected due to normal viral clearance, none of the samples
collected from these tissues at 14, 21, or 28 days p.i. contained
sufficient viral mRNA to be used for microarray analysis, ex-
cept for the SMG.
Comparisons of the viral-gene expression profiles for lung,
liver, kidney, spleen, allograft heart, and SMG are shown in
Fig. 5 and Table 4. As observed for SMG, fewer viral tran-
scripts were detected in infected tissues than in those ex-
pressed in vitro. Moreover, the RCMV gene expression pro-
files appear to be unique to each tissue type. Most of the
tissues expressed genes from each kinetic class (IE, E, and L),
making it difficult to classify in vivo virus replication based on
traditional in vitro replication kinetics. Interestingly, while vi-
ral-gene expression levels were consistently highest in the
SMG, there were more RCMV genes expressed above back-
ground in both spleen and liver than in the SMG. In fact, a
total of 60 viral genes were expressed at levels twofold above
background in the spleen (38% of the RCMV genome) com-
pared to 41 in the SMG (25% of the genome). These findings
indicate that the number of viral genes expressed at detectable
levels in vivo is not dependent upon the viral-DNA copy num-
ber and that the pattern of expression of RCMV genes is tissue
specific. As shown in Table 4, compared to the spleen, a re-
duced number of viral genes were detected in the other organs;
44 viral genes were detected in the liver, 39 in the allograft
heart, 26 in the kidney, and 17 in the lung. A total of nine
FIG. 3. RCMV in vivo gene expression. Fluorescence intensities
from microarray analysis of RCMV mRNA isolated from infected rat
SMG that were harvested at days 7, 14, 21, and 28 days p.i. At each
time point, SMG samples were isolated from four individual infected
rats and analyzed on separate microarray chips. The data shown in-
clude gene intensities acquired from each of these four separate arrays.
TABLE 2. Classification of RCMV gene expression
in cultured rat fibroblasts
IE (4 h) E (PAA;48 h)a L (48 h) IE (4 h)
E (PAA;
48 h)a L (48 h)
IE r123ex4 r2 r2.1 R92
r128 r4 r3 R93
r5 R33 R94
R23 R46 R95
R24 R47 R96
r25.1 R48 R97
R25.3 R52 R98
R25 R53 R99
R26 r70.1 R102
R27 R73 R105
R28 r74 r109
R29 R75 R112ex1
R31 R76 R113
R32 R84 R114
R34 R85 R115
R35 r90 R116
R36 R100 R117
R37 R104 R118
R38 r106 r119.1
r39 r107 r119.2
r40 r110 r119.3
r41 r111.2 r119.4
r42 r121.2 r119.5
r43.1 R121 r119.6
R43 R122ex5 r142
R44 r124 r143
R45 r127 r144
R49 r128 r145
R50 r131 r146
R51 r133 r147
R54 r135 r149
R55 r136 r150
R56 r137 r151.1
R57 r138 r151.3
R69 r139 r151
r70.2 r140 r152.1
r70.3 r151.2 r152.3
r70.4 r152 r152.4
r70.5 r155 r152.5
R72 r168 r157
R77 r158
R78 r160
R80 r161
R82 r162
R83 r164
R87 r166
R88 r167
R91 r171.1
a PAA, phosphonoacetic acid.
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RCMV genes were detected in all of the tissues tested: R78
(vGPCR), R116, r119.2, r119.3, r133, r138 (Fc receptor ho-
molog), r142 (m142 homolog; macrophage tropism determi-
nant), r149, and r152.4. Apart from r133, all of these genes are
expressed with early kinetics in vitro. Five viral genes (R73
[gN], R114, r119.4, r151, and r166) were expressed at detect-
able levels in at least five out of six tissues. Eleven RCMV
genes were detected in four out of six tissues (R28, r41, R80
[assembly protein], R94 [tegument protein], R96 [viral kinase],
R115, r124, r151.1, r152.3, r157 [homolog of murine CMV
m157, which binds Ly49H], and r158), most of which are on the
right half of the viral genome. There were 18 genes uniquely
detected in a single tissue type, and 10 of these genes were
specific for the SMG. As shown in Table 4, a subset of genes
expressed in each tissue were not detectable; some of the
weakly expressed genes scored negative because their intensi-
ties were below the detection limit of the microarray assay
(0.5  104 to 1  104 copies/2 g of total RNA). We attribute
differences in detection to the level of virus infection, which
varies between individual rats (Table 3). In general, the genes
that are consistently detected in vivo are regarded as dispens-
able for virus replication in vitro and may be involved in im-
mune evasion, cell cycle manipulation, antiapoptosis, and/or
cell survival. These regulatory genes potentially include nine
members of the m145 gene family and seven of the US22 gene
family.
In order to confirm the tissue-specific expression pattern of
RCMV genes, QRT-PCR was performed in triplicate on mRNAs
isolated from the tissues of three individual rats. TaqMan probes
and primers specific for R78, r119.1, r119.2, r151, and r152.4 were
generated. Average copy numbers were normalized to expression
of the cellular housekeeping gene L32, and the ratio between
each pair of genes was determined (Fig. 6). Three of the genes,
r119.2, r151, and r152.4, were highly expressed at similar levels in
all of the tissues that were tested. The expression of these genes
was at most threefold different (r119.2/r152.4 in the native heart
FIG. 4. Confirmation of in vivo RCMV gene expression. RT-PCR TaqMan analysis was used to confirm and quantify viral-gene expression in
RNA samples from (A) in vivo-infected SMG at 7, 14, 21, and 28 days p.i. and (B) in vitro-infected rat fibroblasts. Primers specific for the RCMV
genes R75 (gH), R114, R116, r119.1, r119.2, r119.4, R123 (IE1), and r151 were used to quantify viral-gene expression. RNA samples were
normalized to expression of L32 (cellular ribosomal protein), and the relative copy numbers were determined using plasmids containing each viral
gene. The error bars indicate standard deviations.
TABLE 3. Detection of RCMV DNA
Day Tissue
No. of copies for animala:
1 2 3 4 Avg
7 Graft heart 2.5  105 9.8  103 6.6  105 5.0  103 2.3  105 	 3.1  105
Spleen 0 5.2  105 0 0 1.3  105 	 2.6  105
Lung 3.6  104 8.8  104 8.4  104 6.9  103 5.4  104 	 3.9  104
Liver 2.5  105 5.1  104 1.6  105 1.4  104 1.2  105 	 1.1  105
Kidney 9.0  104 3.3  104 1.6  105 0 7.2  104 	 7.1  104
Salivary gland 2.6  105 9.2  104 2.0  104 1.5  105 1.3  105 	 1.0  105
14 Salivary gland 1.0  107 4.6  106 3.3  107 2.3  107 1.8  107 	 1.3  107
21 Salivary gland 5.9  108 8.0  108 1.9  107 6.5  107 3.7  108 	 3.9  108
28 Salivary gland 2.3  108 2.2  107 2.6  107 4.5  107 1.4  108 	 1.2  108
a Genomic copies per 1 g of total DNA determined by quantitative PCR (TaqMan).
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samples), which was not statistically significant (P  0.15). R78
and r119.1 were two of a number of genes that, according to our
microarray analysis, appeared to be expressed in a tissue-specific
manner. In all tissues tested, R78 and R119.1 were expressed at
similar levels, except the SMG, where r119.1 was expressed at a
considerably higher level (approximately 60-fold) than was R78.
By contrast, R78 expression in RCMV-infected REFs at 24 h p.i.
was significantly higher than that of both r119.1 and r119.2. Ex-
pression levels for r119.1 in the allograft heart and SMG tissues
was increased relative to R78, whereas the expression levels of
these two genes were similar in the liver, lung, kidney, and spleen.
Compared to expression levels of r119.2, r151, and r152.4, r1191.1
was dramatically lower in these tissues. This is an interesting
finding, since these infected tissues express a unique viral tran-
scriptome. For example, in the spleen, 61 genes are expressed to
detectable levels, whereas 44 and 17 genes are expressed in the
liver and lung, respectively. The expression levels of r119.1 in
allograft hearts and SMG were similar to those of r119.2, r151,
and r152.4 (Fig. 4A and 6), suggesting that expression of these
genes may be similarly controlled.
DISCUSSION
Originally, our plan for these studies was to compare RCMV
gene expression in only allograft versus native hearts to deter-
mine the viral mechanisms associated with CMV-accelerated
allograft rejection and vascular disease. However, after profil-
ing other tissues from the infected transplant recipients, it
became evident that there were major differences in viral-gene
expression between the various tissues. Because of these sig-
nificant findings, we expanded our study to include all major
tissues in the transplant recipient. In the current report, we
used a global microarray approach to examine RCMV gene
expression in infected cultured cells and in tissues from in-
fected rats. By studying CMV gene expression at the viral-
transcriptome level, we avoided biasing this study toward a
limited number of viral genes. This process has enabled us to
identify the viral-gene expression profiles during acute infec-
tion of heart transplant recipients. In cultured cells, RCMV
expresses approximately 95% of the known viral ORFs, and we
observed very little difference in the expression patterns be-
tween infected SMC, EC, and fibroblasts. However, viral-gene
expression in tissues from infected rat heart allograft recipients
was very different. The results from the in vivo transcription
analysis allow the following conclusions to be drawn. (i) The
profiles and amplitude of viral-gene expression differed dra-
matically compared to infected cultured cells, indicating that
CMV gene expression in vitro does not accurately reflect viral-
gene expression in vivo. (ii) Viral-gene expression in tissues is
skewed toward genes that are not known to have direct roles in
virus replication or assembly but most likely represent genes
involved in immune evasion or host cell survival. Other viral
genes are expressed, as detected by RT-PCR; however, the
expression levels are below the detection threshold of the mi-
croarray assay. (iii) The viral-DNA load and viral-mRNA lev-
els do not correlate with profiles of gene expression. (iv) Viral-
gene expression is tissue specific, suggesting either that the
virus actively adapts to its environment in order to control gene
expression or that CMV merely passively responds to tran-
scriptional controls implemented by the host environment. Our
findings emphasize the importance of in vivo analysis using
animal models in translational research.
The first global analysis of CMV gene expression was per-
formed by Chambers et al. using microarray chips designed to
151 of the 200 known HCMV ORFs (8). This study demon-
strated the feasibility of microarray technology to monitor the
gene expression profiles of large complex viruses, such as the
herpesviruses. They determined the temporal kinetic class of
each of the HCMV ORFs, including those of many uncharac-
FIG. 5. Microarray analysis of RCMV gene expression in in-
fected rat tissues. Total RNA was extracted from RCMV-infected
spleen, lung, kidney, and heart allograft at 7 days p.i.; SMG at 21
days p.i. The RNA was processed and analyzed using our RCMV
microarray chips (n  4). The mean gene intensity from each of the
four biological replicates is plotted on the y axis, and RCMV gene
number on the x axis.
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TABLE 4. RCMV gene expression in rat tissues
RCMV/ORF
Intensitya
Comments
Spleen Lung Liver Kidney Salivarygland
Allograft
heart
r2 0 0 0 0 0 690
r2.1 809 0 4,420 1,239 0 0
r4 1,009 0 1,122 0 0 0
r5 0 0 754 0 0 0
r6 0 0 0 548 0 0
R23 594 0 744 0 0 0 US22 family homolog
r25.1 1,462 0 777 0 0 2,319 US22 family homolog
R25 1,158 0 504 0 0 1,917 UL25 family homolog
R27 583 0 0 0 0 1,024
R28 1,434 0 632 823 0 1,160
R29 647 0 0 5,504 0 949
R31 455 0 0 0 0 0
R35 0 0 0 0 3,058 0 UL25 family homolog
R36 686 0 903 0 0 0 US22 family homolog
R38 901 0 982 0 0 942
r41 1,650 602 1,403 0 0 705
r42 0 0 0 496 0 0
R43 976 0 0 0 1,135 1,568 US22 family homolog
r43.1 0 0 1,109 0 0 844
R45 636 0 895 0 0 639 Homolog of HCMV gene encoding RRL
R49 1,356 0 0 628 0 905
R54 0 0 0 0 767 0 DNA polymerase
R55 683 0 0 0 754 2,929 glycoprotein B
R69 861 0 827 0 0 0 Transactivator of gene expression
r70.2 4,172 0 555 0 0 4,452 m145 gene family member
r70.3 1,175 0 0 0 0 1,534 m145 gene family member
r70.5 0 0 884 0 0 0 m145 gene family member
R72 0 0 0 0 1,034 0 UTPase
R73 1,779 0 454 658 2,286 2,143 gN
R78 4,519 1,812 7,293 777 1,274 1,819 GPCR gene homolog
R80 3,347 0 0 725 6,118 4,571 Assembly protein
R82 0 0 809 0 1,747 1,244 Upper matrix protein homolog
R88 636 0 0 0 0 740
R93 687 0 0 0 0 2,272
R94 2,938 0 637 918 0 2,436 Tegument protein
R95 666 0 0 0 0 796
R96 2,382 0 0 464 969 1,514
R98 738 0 0 0 0 0 Exonuclease (DNase)
R99 1,276 0 0 474 0 2,106 Tegument phosphoprotein
R100 1,416 0 0 0 1,592 3,542 Glycoprotein M
R102 1,526 0 0 0 1,405 1,955 HP complex component
r106 734 0 607 0 0 0
r109 1,576 0 0 523 0 1,859
r110 544 0 0 0 0 0
R113 1,677 0 789 0 1,083 0
R114 5,259 0 736 1,396 21,637 6,256 Uracil DNA glycosylase
R115 849 0 0 665 4,678 1,518 Glycoprotein L
R116 10,322 865 1,434 3,268 10,578 6,189
R118 0 0 0 0 665 0
r119.1 556 0 0 0 27,712 0
r119.2 11,846 5,237 18,217 6,721 52,110 1,885
r119.3 6,881 3,255 9,417 1,577 38,222 976
r119.4 1,974 972 2,064 691 6,389 0
r119.6 0 0 0 0 420 0
r124 2,862 2,517 2,825 0 765 0
r128 1,364 0 2,001 0 675 0 US22 family homolog
r133 4,697 2,610 7,068 567 1,748 1,362 Homolog of murine CMV SGG1
r138 7,498 3,389 9,199 856 1,681 2,048 Fc receptor
r139 0 0 849 0 0 0 US22 family homolog
r142 3,164 597 1,954 814 1,464 3,625 US22 family homolog
r146 0 0 0 0 1,084 0
r147 0 0 0 0 720 0
r149 4,337 1,976 4,075 922 5,653 593
r150 1,068 0 1,462 0 2,042 0 m145 gene family member
r151.1 958 644 1,652 0 1,787 0
Continued on following page
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terized ORFs. An interesting finding of this study was that
many of the genes in a specific temporal class contain common
potential regulatory motifs within their promoter regions, sug-
gesting that HCMV can express its genes with specific tran-
scriptional programs, much like what is observed in tissues
during development. Our results demonstrate that the in vivo
gene profiles for RCMV are different from those observed in
cultured cells and that the viral-gene expression pattern is
tissue specific. An explanation for our findings of limited in
vivo viral-gene expression is that the multiplicity of infection in
the tissues is low or that clearance of the productively infected
cells leaves only abortively infected cells that express fewer
genes to high levels. Our data do not support or directly refute
these scenarios. On the contrary, we detected the highest viral
titers in the SMG between days 21 and 28, during the time of
limited viral-gene expression. Thus, another explanation may
involve the number of different infected cell types per tissue;
the more types of infected cells, the wider the viral-gene pro-
file. Interestingly, infection in the SMG is limited to the stri-
ated duct cells (15), and the number of highly expressed genes
is limited to 41 in this tissue. Other tissues, like the spleen,
display a wider viral-gene profile, and multiple cell types may
be infected. However, the fact that RCMV gene expression
occurs in a tissue-specific manner suggests that there exists a
TABLE 4—Continued
RCMV/ORF
Intensitya
Comments
Spleen Lung Liver Kidney Salivarygland
Allograft
heart
r151.3 599 0 0 0 3,071 0
r151 2,077 1,487 1,837 570 13,367 0 m145 gene family member
r152.2 0 0 0 0 829 0 m145 gene family member
r152.3 599 1,289 2,350 0 729 0 m145 gene family member
r152.4 15,024 6,077 13,520 6,759 35,768 5,592 m145 gene family member
r152.5 955 0 792 0 0 0
r157 2,044 959 1,828 0 1,453 0 m145 gene family member
r158 1,375 0 631 509 2,805 0
r161 0 0 0 0 435 0
r166 3,333 1,312 5,271 0 564 792
r171.1 461 0 854 0 0 0
r171 780 0 865 0 0 0
Total viral genes
detected per tissue
60 17 44 26 41 39
% of RCMV genome 36 10 27 16 25 24
a The average fluorescence intensity for each viral gene (n  3).
FIG. 6. RCMV gene expression is tissue specific. RT-PCR TaqMan analysis was used to confirm and quantify viral-gene expression in RNA
samples from in vivo-infected native heart, allograft heart, lung, liver, kidney, spleen, and SMG. All tissues were harvested at 7 days p.i., except
SMG (21 days p.i.). RCMV-infected REFs harvested at 24 h p.i. were used for in vitro-in vivo comparisons. Primers specific for the RCMV genes
R78, r119.1, r119.2, r151, and r152.4 were used to quantify viral-gene expression. RNA samples were normalized to expression of L32 (cellular
ribosomal protein), and the relative copy numbers were determined using plasmids containing each viral gene. The limit of detection for this assay
was 100 copies.
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level of transcriptional control at the tissue level. This tissue
specificity suggests that the virus may have multiple transcrip-
tional programs, depending upon the cellular environment, or
that other posttranscriptional events, such as mRNA stability,
may be important to elicit this effect. What we do not yet know
is whether the virus and/or the host cell determines this level of
control. The ability of the virus to control gene expression in a
tissue-specific manner may be regulated by specific motifs
within the viral promoters that are active in some tissues but
not in others. This level of transcriptional control does not
exist in vitro for RCMV-infected cells, where eventually almost
all of the viral ORFs are expressed to a detectable level. We
were unable to detect any obvious regulatory-motif pattern in
the promoters of the RCMV genes that are highly expressed in
vivo. However, a more intensive study is warranted to identify
these regions in order to determine the selective mechanisms
of in vivo gene expression. An interesting parallel in the ability
of CMV to regulate viral-gene expression is observed during
natural human papillomavirus infections of the skin. Papillo-
maviruses contain only two promoters, early and late. The
early promoter is active in many different cell types but appears
to be most active in keratinocytes, suggesting that the pro-
moter is cell/tissue type specific (2, 19, 30). The late promoter
is differentiation dependent and is activated only during ter-
minal differentiation of the epithelial cells of the granular layer
(19). An important question that arises from virus gene ex-
pression studies with papillomavirus and those we present here
is what are the cell-type-specific factors that promote the ac-
tivation of some viral genes and repression of others?
Adamo et al., Bresnahan et al., Goodrum et al., and Heider
et al. utilized similar HCMV microarrays, containing 191 viral
ORFs, to monitor viral-gene expression on a global level (1, 4,
11–13). Utilization of these HCMV microarrays to identify the
viral-gene expression patterns in specific subsets of CD34
hematopoietic stem cells demonstrated that HCMV infection
of these cells produced an initial transient burst of gene ex-
pression, followed by a period of viral transcriptional quies-
cence and genome maintenance. The infected CD34 cells
were capable of reactivating virus when cocultured with fibro-
blasts. The HCMV expression profiles in CD34 cells parallel
our in vivo RCMV gene expression profiles on a number of
levels. First, gene expression in the CD34 cells was signifi-
cantly different from that in HCMV-infected fibroblasts. Sec-
ond, viral expression in CD34 cells was very limited and did
not correspond to conventional IE, E, and L viral-gene expres-
sion profiles. Finally, many of the viral genes expressed in the
CD34 stem cells are not directly involved in virus replication.
The significance of this early burst of viral-gene expression is
not understood. However, it might play a role in the establish-
ment of latency. Clearly many, if not all, of the herpesviruses
can regulate their gene expression patterns during persistence
and latency. For example, Epstein-Barr virus infection of B
cells results in one of five transcriptional programs, depending
upon the activation and differentiation statuses of the host cell
(reviewed in reference 27). Most of these transcriptional pro-
grams are involved in maintaining persistence of the viral ge-
nome during periods of cell quiescence and during cellular
replication. In addition, herpes simplex virus type 1 expresses
the viral latency-associated transcript during all stages of rep-
lication, but it is exclusively expressed during latent infections
of neurons (reviewed in reference 24). Expression of the la-
tency-associated transcript is required for cell survival during
reactivation. Similarly, CMV expression in the SMG (a major
site of virus persistence), even in the presence of high levels of
viral genome, is tightly regulated and highly skewed. The viral
genes expressed in the SMG may be involved in preserving the
infected host cell, allowing immune escape, and/or promoting
transmission to a new host. Thus, a common theme among
these viruses is the ability to control viral-gene expression as a
method of persistence in the infected host, whether it is during
latency or during smoldering infection states, both of which
occur in a CMV-infected host.
Our in vivo observations indicate that gene expression of the
immune modulators occurs at higher levels than previously
predicted based upon in vitro studies. It may be that this
differential level of in vivo viral-gene expression between the
two gene groups responsible for immune evasion and viral
replication allows the virus to persist by turning over small
amounts of infectious virus while remaining relatively undetec-
ted by the host immune system. A relevant question that sur-
faces from these findings is why the virus specifically overex-
presses certain viral genes and not others. For example, is
there relevance to the fact that in our study the RCMV-en-
coded Fc receptor, r138, was highly expressed in the spleen,
liver, and lung? In these tissues, r138 is expressed at nearly the
same level as r119.2, whereas in the SMG, r138 is expressed at
30-fold lower levels than r119.2 (Fig. 5 and Table 4). Is the
virus more prone to antibody-mediated immune pressures in
the lung, liver, and spleen than in SMG tissues? Our findings
suggest that the virus does not produce its full arsenal of
immune modulator genes in every infected cell type in vivo but
rather selectively regulates their respective gene expressions.
The host response to viral infection is probably not the same in
every tissue. Thus, the ability of CMV immune evasion genes
involved in preventing immune recognition would similarly
need to be specific for each of these types of responses. Con-
sequently, the virus would need to express multiple transcrip-
tional programs appropriate for the specific host cell type and
the type of immune response prompted by the infected cell
and/or by its juxtaposition to the immune system.
In conclusion, we explored the characteristics of RCMV
gene expression in cultured cells and in tissues from a rat
cardiac transplant model. Combined, our findings indicate that
viral-gene expression is highly complex. One cannot predict in
vivo viral-gene expression solely based upon the in vitro viral-
transcriptome analysis. In fact, most studies aimed at identify-
ing viral expression during latency and reactivation have fo-
cused on the IE proteins, which we found to be expressed at
very low levels compared to the other viral genes likely in-
volved in immune modulation. The most efficient and effective
way for CMV to remain undetected by the host during persis-
tence is by regulating viral-gene expression in such a way as to
overexpress the immune evasion genes while repressing viral
genes involved in replication. One of the reasons that CMV
carries so many genes might be that different gene expression
programs are used in different cell and tissue types. This is also
highly relevant for the analysis of immune modulators. If the
wrong tissues and organs are studied, the effect might be
missed. Identifying the viral transcriptomes of different tissues
and at different times associated with virus-induced disease,
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such as accelerated allograft rejection, will aid in the design of
novel targeted therapeutics.
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